NAFDAC has destroyed unwholesome products valued at ₦22.73 billion between January and August 2026, alongside thousands of enforcement operations, as the agency intensifies efforts to protect public health and strengthen Nigeria’s pharmaceutical regulatory system.
The National Agency for Food and Drug Administration and Control (NAFDAC) says it destroyed unwholesome products valued at ₦22.73 billion between January and August 2026 as part of efforts to strengthen regulatory enforcement and protect public health.
The agency disclosed this in a statement issued on Sunday, November 22, 2026, in Abuja, by its Resident Media Consultant, Mr Olusayo Akintola.
According to Akintola, the achievement formed part of the agency’s 2026 performance scorecard presented at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19.
He said the scorecard highlighted major achievements in regulatory system strengthening, digital innovation, pharmaceutical manufacturing, enforcement and international collaboration.
Akintola disclosed that NAFDAC recorded 5,542 enforcement activities within the eight-month period, alongside 213 raids, 821 product seizures, the closure of 179 premises, 52 arrests and 221 sanctions.
He described the agency’s sustained World Health Organisation (WHO) Maturity Level 3 status and ongoing transition towards Maturity Level 4 as another significant milestone.
Maturity Level 4 represents the highest level under the WHO Global Benchmarking Tool for assessing national regulatory authorities.
The statement identified several digital initiatives supporting the transition, including the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS) and GMP Inspection (GMPi).
Other initiatives include application and AI-assisted Technical Screening Tools (TST) and the revised Med-Safety App, designed to strengthen reporting of substandard and falsified medical products as well as adverse drug reactions.
On pharmaceutical manufacturing, Akintola said NAFDAC had recorded significant progress through its 5+5 Policy, with more than 70 per cent of finished pharmaceutical products and 36 products now being manufactured locally.
He said the policy was designed to reduce Nigeria’s dependence on imported medicines and strengthen national medicine security.
The agency’s growing influence across Africa was also highlighted, with Nigeria emerging as a reference National Regulatory Authority and hosting regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking.
Akintola further disclosed that Nigeria had ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on October 25, 2026.
He attributed the achievements to the strategic leadership of NAFDAC’s Director-General, Prof. Mojisola Adeyeye, whose administration has prioritised institutional transformation, science-based regulation, digital innovation and international regulatory cooperation.
“NAFDAC continues to strengthen its regulatory capacity; enhance public health protection; and position Nigeria as a leading regulatory authority in Africa,” the statement said.
Visit GMTNewsng for more news stories.


